Cargando…

In silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions

P-glycoprotein (P-gp) is an ATP (adenosine triphosphate)-binding cassette transporter that causes multidrug resistance of various chemotherapeutic substances by active efflux from mammalian cells. P-gp plays a pivotal role in limiting drug absorption and distribution in different organs, including t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shityakov, Sergey, Förster, Carola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969253/
https://www.ncbi.nlm.nih.gov/pubmed/24711707
http://dx.doi.org/10.2147/AABC.S56046
_version_ 1782309241075269632
author Shityakov, Sergey
Förster, Carola
author_facet Shityakov, Sergey
Förster, Carola
author_sort Shityakov, Sergey
collection PubMed
description P-glycoprotein (P-gp) is an ATP (adenosine triphosphate)-binding cassette transporter that causes multidrug resistance of various chemotherapeutic substances by active efflux from mammalian cells. P-gp plays a pivotal role in limiting drug absorption and distribution in different organs, including the intestines and brain. Thus, the prediction of P-gp–drug interactions is of vital importance in assessing drug pharmacokinetic and pharmacodynamic properties. To find the strongest P-gp blockers, we performed an in silico structure-based screening of P-gp inhibitor library (1,300 molecules) by the gradient optimization method, using polynomial empirical scoring (POLSCORE) functions. We report a strong correlation (r(2)=0.80, F=16.27, n=6, P<0.0157) of inhibition constants (Ki(exp) or pKi(exp); experimental Ki or negative decimal logarithm of Ki(exp)) converted from experimental IC(50) (half maximal inhibitory concentration) values with POLSCORE-predicted constants (Ki(POLSCORE) or pKi(POLSCORE)), using a linear regression fitting technique. The hydrophobic interactions between P-gp and selected drug substances were detected as the main forces responsible for the inhibition effect. The results showed that this scoring technique might be useful in the virtual screening and filtering of databases of drug-like compounds at the early stage of drug development processes.
format Online
Article
Text
id pubmed-3969253
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-39692532014-04-07 In silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions Shityakov, Sergey Förster, Carola Adv Appl Bioinform Chem Original Research P-glycoprotein (P-gp) is an ATP (adenosine triphosphate)-binding cassette transporter that causes multidrug resistance of various chemotherapeutic substances by active efflux from mammalian cells. P-gp plays a pivotal role in limiting drug absorption and distribution in different organs, including the intestines and brain. Thus, the prediction of P-gp–drug interactions is of vital importance in assessing drug pharmacokinetic and pharmacodynamic properties. To find the strongest P-gp blockers, we performed an in silico structure-based screening of P-gp inhibitor library (1,300 molecules) by the gradient optimization method, using polynomial empirical scoring (POLSCORE) functions. We report a strong correlation (r(2)=0.80, F=16.27, n=6, P<0.0157) of inhibition constants (Ki(exp) or pKi(exp); experimental Ki or negative decimal logarithm of Ki(exp)) converted from experimental IC(50) (half maximal inhibitory concentration) values with POLSCORE-predicted constants (Ki(POLSCORE) or pKi(POLSCORE)), using a linear regression fitting technique. The hydrophobic interactions between P-gp and selected drug substances were detected as the main forces responsible for the inhibition effect. The results showed that this scoring technique might be useful in the virtual screening and filtering of databases of drug-like compounds at the early stage of drug development processes. Dove Medical Press 2014-03-24 /pmc/articles/PMC3969253/ /pubmed/24711707 http://dx.doi.org/10.2147/AABC.S56046 Text en © 2014 Shityakov and Förster. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Shityakov, Sergey
Förster, Carola
In silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions
title In silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions
title_full In silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions
title_fullStr In silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions
title_full_unstemmed In silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions
title_short In silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions
title_sort in silico structure-based screening of versatile p-glycoprotein inhibitors using polynomial empirical scoring functions
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969253/
https://www.ncbi.nlm.nih.gov/pubmed/24711707
http://dx.doi.org/10.2147/AABC.S56046
work_keys_str_mv AT shityakovsergey insilicostructurebasedscreeningofversatilepglycoproteininhibitorsusingpolynomialempiricalscoringfunctions
AT forstercarola insilicostructurebasedscreeningofversatilepglycoproteininhibitorsusingpolynomialempiricalscoringfunctions